Navigation Links
Major US Airline Discriminates Against Disabled Passenger, Lawsuit Charges
Date:10/5/2007

Dystonia-Affected Man Files Lawsuit Against U.S. Airways for Denying Right to Fly; Case Could Set Precedent for Airline Travel Rights of Persons with

Disabilities

JACKSONVILLE, Fla., Oct. 5 /PRNewswire/ -- A 26-year-old disabled man, who was denied access to a U.S. Airways flight in June, has sued the major airline for discrimination.

Andy Gates is affected by dystonia, an obscure neuromuscular movement disorder that causes muscles to spasm and contract uncontrollably. Although he uses a wheelchair, he can cross short distances without assistance.

Frequently misdiagnosed as cerebral palsy or psychiatric illness, dystonia is estimated to affect no less than 300,000 people in North America are affected, one third of whom are children.

In June, as he was about to board a flight to Milwaukee, Wisconsin, Gates was stopped by a U.S. Airways shift manager. According to the lawsuit, the manager said the captain of the airplane felt, based on Gates' appearance, that he was too disabled to fly unaccompanied. After a few attempts to explain that Gates was already preauthorized by the airline to fly, he was ultimately denied access.

"All I wanted to do was to safely get to my destination. I've flown many times alone before this incident," said Gates. "It's unfair that someone simply looked at me and made a snap judgment about what I can or cannot do."

Gates recently filed a lawsuit against U.S. Airways and a formal complaint with the U.S. Department of Transportation. Though the Americans With Disabilities Act does not apply to air travel, the federal Air Carrier Access Act prohibits airlines from discriminating on the basis of disability.

However, there is no federal, private right of action available to individuals discriminated against because of their disability in terms of air travel.

"This alleged act of discrimination is unacceptable and sends a message that more needs to be done to educate the public about disabilities such as dystonia," said Janet Hieshetter, Executive Director of the DMRF. "Dystonia comes in all forms and despite some of the challenges this disorder brings, many dystonia-affected individuals lead successful, independent, and fulfilling lives."

About Dystonia

Dystonia is a movement disorder that causes the muscles to contract and spasm involuntarily. The contractions force the body into repetitive and often twisting movements as well as awkward, irregular postures. There are approximately 13 forms of dystonia, and dozens of diseases and conditions include dystonia as a significant symptom.

Dystonia may affect a single body area or be generalized throughout multiple muscle groups. Dystonia affects men, women, and children of all ages and backgrounds. Dystonia causes varying degrees of disability and pain, from mild to severe. There is presently no cure, but multiple treatment options exist and scientists around the world are actively pursuing research toward new therapies.

Founded in 1976, the Dystonia Medical Research Foundation is dedicated to serving the needs of all persons affected with dystonia and their families. DMRF's mission is to advance research for more effective treatments and ultimately a cure, to promote awareness and education, and to support the needs and well-being of affected individuals and families. For more information visit http://www.dystonia-foundation.org.


'/>"/>
SOURCE Dystonia Medical Research Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Pharma majors gear to supply anti-anthrax drug
2. First Artificial Heart patient has Major setback
3. Allergies: A major health problem
4. Animal insulin product to be discontinued by drug major Eli Lilly
5. Vision Loss Due To Diabetic Retinopathy a Major Cause Of Concern
6. Depression Found To Be A Major Cause for Death in Elderly
7. Genetics Has A Major Role To Play In Body Shape.
8. “Yes, I need Cosmetic surgery” – view of majority wome
9. Pigs Population A Major Threat To Encephalitis Ravaged UP
10. Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India
11. Delhi Government To Interlink All Major Hospitals Through e-Governance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Getting enough sleep affects much more than energy ... going just 19 hours without sleep can compromise motor reaction time, which can increase the ... Amica Insurance is sharing the following tips from the NSF to help you sleep better ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... Patel M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is ... Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta ...
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and are ... had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, founder ... Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on his ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates ... leading ERP expert that specializes in long-term care, Brooke Grove now has the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: